Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma
| Conditions: | Pleural Malignant Mesothelioma |
| Start Date: | April 1, 2010 |
| Phase: | Phase II |
| Status: | Recruiting |
| NCT ID: | NCT01112293 |
| Study Type: | Interventional |
| Intervention: | Drug: GC1008 |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Abramson Cancer Center of the University of Pennsylvania |
| Ages: | Adult|Senior |
| Enrollment: | 20 |
| Funded By: | Other |
| First Received: | April 27, 2010 |
| End Date: | |
| Last Updated: | September 21, 2010 |
| Last Verified: | September 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
